Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesPayablesPrepaid AssetsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Accumulated Expenses (2020 - 2025)

Journey Medical (DERM) has disclosed Accumulated Expenses for 6 consecutive years, with $2.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Accumulated Expenses fell 19.24% year-over-year to $2.1 million, compared with a TTM value of $2.1 million through Sep 2025, down 19.24%, and an annual FY2024 reading of $3.4 million, up 15254.55% over the prior year.
  • Accumulated Expenses was $2.1 million for Q3 2025 at Journey Medical, up from $990000.0 in the prior quarter.
  • Across five years, Accumulated Expenses topped out at $23.0 million in Q1 2025 and bottomed at $22000.0 in Q4 2023.
  • Average Accumulated Expenses over 5 years is $4.1 million, with a median of $2.4 million recorded in 2023.
  • The sharpest move saw Accumulated Expenses tumbled 99.57% in 2023, then skyrocketed 15254.55% in 2024.
  • Year by year, Accumulated Expenses stood at $2.7 million in 2021, then tumbled by 94.08% to $160000.0 in 2022, then crashed by 86.25% to $22000.0 in 2023, then surged by 15254.55% to $3.4 million in 2024, then tumbled by 38.13% to $2.1 million in 2025.
  • Business Quant data shows Accumulated Expenses for DERM at $2.1 million in Q3 2025, $990000.0 in Q2 2025, and $23.0 million in Q1 2025.